Blue Trust Inc’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.7K Hold
893
﹤0.01% 1120
2025
Q4
$80.3K Sell
893
-122
-12% -$11.6K ﹤0.01% 1163
2025
Q3
$100K Buy
1,015
+62
+7% +$6.14K ﹤0.01% 1069
2025
Q2
$86.9K Buy
953
+31
+3% +$3K ﹤0.01% 1101
2025
Q1
$104K Sell
922
-104
-10% -$11.1K ﹤0.01% 968
2024
Q4
$108K Sell
1,026
-693
-40% -$74.4K ﹤0.01% 905
2024
Q3
$187K Buy
1,719
+1,071
+165% +$117K ﹤0.01% 893
2024
Q2
$85.5K Buy
648
+59
+10% +$6.96K ﹤0.01% 1035
2024
Q1
$77.7K Buy
589
+120
+26% +$15K ﹤0.01% 779
2023
Q4
$52K Buy
469
+153
+48% +$17.1K ﹤0.01% 926
2023
Q3
$46K Buy
316
+5
+2% +$635 ﹤0.01% 878
2023
Q2
$40K Sell
311
-280
-47% -$38.1K ﹤0.01% 777
2023
Q1
$75K Buy
591
+3
+0.5% +$377 ﹤0.01% 863
2022
Q4
$61K Buy
588
+177
+43% +$20.5K ﹤0.01% 844
2022
Q3
$43K Buy
411
+122
+42% +$13.4K ﹤0.01% 811
2022
Q2
$37K Buy
+289
New +$34.3K ﹤0.01% 780

Other funds holding ZBH

Blue Trust Inc's ZBH Position: Q1 2026 in Review

Blue Trust Inc held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 893 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1120.

Blue Trust Inc first reported a position in ZBH in Q2 2022 and has held it in 16 quarters since. The position peaked at $187K in Q3 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Blue Trust Inc held 893 shares of Zimmer Biomet worth $80.7K as of Q1 2026.
  • Blue Trust Inc left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1120 holding.
  • Blue Trust Inc first reported a position in Zimmer Biomet in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's Zimmer Biomet position peaked at $187K in Q3 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.